Jazz Pharmaceuticals plc XNAS: JAZZ

Mid-range Performer

Download real time

129.50 1.48 (1.16%)

35.62% Gain from 52W Low

718.4K

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Jazz Pharmaceuticals plc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents